Category Archives: MIT Holding MITD

MIT Holding, Inc. (MITD) Industry-Changing Solutions Address Key Post-Care Concerns

October 1, 2015

MITD logo

You could assume plenty of reasons someone may not be a fan of going to the hospital. Fears of doctors, needles and tests aside, many people simply cringe at the aftermath of a hospital: recovery and bill management.

MIT Holding provides professional outpatient medical care with ambulatory infusion therapies, home infusion services and medical equipment delivery. At the core of its operations, MIT Holding is addressing the mayhem associated with hospital discharge and subsequent at-home recovery, working through its growing network of accredited agents, facilitators and contractual obligations to operate as a single-source provider of the aforementioned services.

From the time of patient discharge from the medical facility, MITD handles everything pertaining to the at-home recovery phase, including in-home medical equipment, infusion services, medications, follow-up appointments, organize therapy sessions, wound dressings, transportation. This saves the patient and their caretakers with significant convenience and assistance through what might otherwise become a burdensome task that delays full recovery.

MITD’s goal here is to make sure there is no lapse in patient care or communication. Furthermore, the digital paperwork MIT maintains in order to monitor the patient’s recovery contains all the information the hospital and doctors need to comply with the industry rules.

Another advantage is that MITD meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. Because the company handles insurance inquires and professional insurance claim billing, mounting claims, bills and calls to insurance companies are no longer an insurmountable task.

The company also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Revolutionary to the broader healthcare industry, MITD’s sails are starting to catch wind as it sees the fruition of its reorganization strategy implemented in 2014. The company last month reported that sales for the first six months were $851,724, an increase over sales of $473,153 for the same period of 2014. Adjusted net income for the period was $265,967, or $0.0027 per diluted share. In a GAAP basis, MITD’s first six months of 2015 earned a gross profit of $631,725 compared to $312,240 for the comparable period of 2014.

For the six-month period ended June 30, 2015, MITD produced a per share profit on 202% increase in revenues, as compared to the same period of 2014, reflecting a 37% increase in receivables.

“We are pleased with the strong financial and operational performance of our reorganization strategy. The first six months of profit and growth validate our strategy and approach to our business model,” MITD Chief Executive Officer Walter Drakeford stated in a previous news release. “The unabated growth in the medical industry is creating headwinds, contributing to our continued growth and profitability. The MITD concept of bringing together all necessary services and products under one umbrella for a patient’s post-medical event recovery is, to our knowledge, the first in the industry.”

For more information, visit http://mitholdinginc.com/

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Prepared to Build on Profitable Results through National Expansion Efforts

September 18, 2015

MITD logo

Since implementing its updated corporate goals at the beginning of 2014, MIT Holding, Inc. has made tremendous progress toward capitalizing on the steady growth of the medical industry. In the second quarter of 2015, this progress materialized into the first profitable quarter in the company’s history, as well as an 80 percent year-over-year increase in total sales. With profitability achieved, MITD is now firmly focused on promoting national expansion through both organic growth and strategic acquisitions. Through these efforts, the company will look to continue refining its first-of-its-kind, comprehensive recovery concept, which facilitates and assists patients from the time of their release from a hospital through to a full in-home recovery.

“The first six months of profit and growth validate our strategy and approach to our business model,” Walter Drakeford, chief executive officer of MITD, stated in a news release. “The unabated growth in the medical industry is creating headwinds, contributing to our continued growth and profitability.”

MITD is also benefitting from the medical industry’s ongoing shift toward value-based purchasing options. Rather than continuing to reward healthcare providers based solely on volume of care delivered, the U.S. Department of Health and Human Services (HHS) has recently pushed for a move toward less expensive, value-based care. In 2014, an estimated 20 percent of Medicare reimbursements had shifted away from volume-based payment frameworks, and HHS has set a goal to have 85 percent of Medicare fee-for-service payments in value-based purchasing categories by 2016.

As a result of this market shift, the United States home infusion market is expected to achieve steady growth moving forward, climbing at a compound annual growth rate of just over 9 percent through 2020. According to a report by Harris Williams & Co., home or alternate site home infusion services present patients with a dramatic 90 percent daily cost savings as compared to receiving the same services in a traditional hospital setting.

With its first quarter of profitability now in the books and an established expansion plan in place, MITD is in a favorable position to capitalize on the pivot toward value-based care options while continuing to promote market growth. Look for the company to lean on the marketability of its comprehensive recovery concept, as well as the strong performance of the medical industry, in order to promote sustainable returns.

For more information on MIT Holding, visit http://mitholdinginc.com/

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Solicits Shareholder and Investor Opinions on the Difference between a Good and Bad Investment

September 8, 2015

MITD logo

MIT Holding Inc. believes the investment story and opportunity offered to date to the general investment community has not resonated. They are now respectfully asking shareholders and investors for their opinions. MIT Holding wants you to tell them how they can better disseminate company information. Good or Bad!

Please CLICK THIS LINK (http://dtn.fm/mitd-survey) to answer up to 7 questions you think the company should hear about today. The questions ask about financial, business model, website, disclosures, story line and news.

Please afford a few minutes of your time and respond to this request.

END OF ARTICLE

MIT Holding, Inc. (MITD) – Moves From Re-Org to Acquisition Phase

September 2, 2015

MITD logo

The steady growth of the medical industry is creating ripples, contributing to the sustained growth and profitability that healthcare companies like MIT Holding (OTC: MITD) are experiencing. Following the initiation of reorganization with several strategic initiatives in 2014, MIT Holding has established profitability and is set to achieve positive net profits for this year. The evidenced profitability substantiates the company’s business model, as well as its approach to the developing Affordable Health Care Act (a.k.a. Obamacare) and its resulting impact on the health services industry.

MIT Holding has worked at implementing its first-in-the-industry concept of bringing together, under one umbrella, all of the services and products needed for a patient’s post-medical event recovery. Through agents, facilitators and contractual obligations, the company has ensured that it can provide expert outpatient medical care via ambulatory infusion therapies, home infusion services and medical equipment delivery.

This umbrella of services will allow MIT Holding to make an acquisition of a local pharmacy, clinic, lab or other targeted medical facility, with “overnight” incentives to the owners. For example with MIT Holdings direct billing ability to over a hundred insurance carriers, an acquisition can immediately begin offering additional products and services they had neglected in the past do to inability to bill and receive payment for those services. MIT Holding will free up owners and personal from hours of weekly billing hassles, so they can dedicate 100% of their efforts to core growth.

One of the reasons for the current corporate structure of MIT Holding was to take the burden of administration off of the local facility. This gives the employees the ability to offer superior care and attention to the patient, which in turn echoes up the “referral food chain” families, doctors and hospitals, who in turn refer additional patients to the MIT Holding system.

The patient’s prescriptions, doctors, hospitals and medical needs will constantly change throughout their lives. MIT Holding will always be there. The patient has one constant they can count on through simple and difficult medical events, MIT Holding.

To support its core services, MIT Holding also:

– offers professional accounting, advisory, legal and educational services to physicians, medical centers, hospitals and small and large businesses regarding the Affordable Care Act (a.k.a. Obamacare) and Meaningful Use Rules (MUR);

– provides travel and transportation services to medically-challenged patients with medical needs or in need of personal travel; and

– conducts and administers FDA clinical trials that have been approved through its contracts.

Operationally, MIT Holding meets and or, exceeds major U.S. health insurance requirements so it is able to bill and receive payments directly from the carriers, on behalf of patients. This capability is particularly significant to the company’s mission of developing a profitable first-of-its-kind seamless transition for patients, from their hospital bed discharge to their complete home recovery.

For more information, visit http://mitholdinginc.com/

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Posts First Quarter of Profitability in Company History

August 26, 2015

MITD logo

MIT Holding, a Los Angeles-based company operating through its network of agents, facilitators and contractual obligations to offer professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery, this morning reported its financial results for the 2015 second quarter, marking the company’s first quarter of profitability.

Key points include:

• MITD’s sales for the first six months were $851,724, an increase over sales of $473,153 for the same period of 2014. Adjusted net income for the period was $265,967, or $0.0027 per diluted share.
• On a GAAP basis, MITD’s first six months of 2015 earned a gross profit of $631,725 compared to $312,240 for the comparable period of 2014.
• Receivables increased to $286,853 as compared to $208,269 for the same period of 2014.
• The six-month period ended June 30, 2015, produced a per share profit on 202% increase in revenues, as compared to the same period of 2014, reflecting a 37% increase in receivables.
• MITD is currently in the process of completing corporate audits to become fully compliant with the SEC by year-end 2015.

“After implementing our corporate goals on January 1, 2014, we experienced normal growing pains and produced a profitable and solid company in 18 months. The business plan is now firmly entrenched in the expansion phase. In addition to organic growth goals of 20-25% per year on existing business, we expect acquisitions and the opening of new facilities in untapped geographic locations throughout the United States. When we cannot locate a sound acquisition for purchase within a target market, MIT Holding has the ability to ‘open from scratch’ facilities that will host our products and services,” Tommy Duncan, president of MIT Holding, stated in the news release.

MIT Holding Chief Executive Officer Walter Drakeford commented on industry challenges and the company’s unique position in the medical market.

“We are pleased with the strong financial and operational performance of our reorganization strategy. The first six months of profit and growth validate our strategy and approach to our business model. The unabated growth in the medical industry is creating headwinds, contributing to our continued growth and profitability. The MITD concept of bringing together all necessary services and products under one umbrella for a patient’s post-medical event recovery is, to our knowledge, the first in the industry,” he stated.

The company also announced it will hold an upcoming investors conference call prior to the end of third quarter September 30, 2015. Date, time and dial-in instructions will be released two weeks prior to the call.

For more information visit http://mitholdinginc.com/

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding (MITD) Identifies Industry Transition to Value-Based & Ambulatory Care; Moves to Profitability as a Result

August 24, 2015

MITD logo

The continued growth of the ambulatory (outpatient) care market is driven by a number of emergent factors. The increase in life spans have incubated a prevalence of diseases such as diabetes and COPD (chronic obstructive pulmonary disease) among an increasingly elderly population of retiring Baby Boomers. Insurance carriers are now authorizing payments for more services that that result in more affordable convenience and logistical efficacy of home-based recuperation for these patients, with cost savings of up to 65 percent for minimally invasive procedures when performed at home or in an ambulatory care center. However, it is extremely difficult for already overburdened families to successfully arrange and utilize a comprehensive suite of services, such as home-based infusions, access to durable medical equipment (DME), and the benefits of a comprehensive prescription drug program administrated by a pharmacy benefit manager, by a single healthcare provider (PBM).

MIT Holding Inc. (OTC: MITD) has identified this niche and filled it successfully. Moreover, all participants in the ambulatory care market, whether patients, medical facilities or insurance carriers, benefit directly from tight-knit relationships and the kind of well-oiled networking machinery that MIT Holding offers its patients.

This is particularly important as the industry continues rapidly transitioning from Meaningful Use Stage 1 requirements to the much more complex criteria of Stage 2, where robust clinical reporting that is in-line with regulatory and quality-driven initiatives, as well as coordinated care and patient engagement, are paramount. When it comes to Medicare and Medicaid EHR (electronic health record) Incentive Program participation, healthcare information technology (HCIT) continues to open new doors for the ambulatory care market, and this segment of the overall healthcare market stands to deliver optimum results when it comes to the prevailing value-based care initiatives as well. Patient long-term outcomes and customer service are more of a key focus in ambulatory care than in acute hospital care, and this is a major driving factor of the industry’s continued shift toward ambulatory care.

Organized as a single source provider for a wide range of services and products to patients through its network of affiliates and contractors, MIT Holding is able to hit the sweet spot between cost effective care and customer service. The company delivers intravenous infusions for home and ambulatory care center injection via its full service compounding pharmacy, as well as pharmaceuticals, medical equipment for the home, and other home-based healthcare. The typical high cost of specialized infusion pharmacy services can be substantially ameliorated through ambulatory care, and the kind of customized education/counseling that is also required to get the patient situated regarding their condition and the requisite treatments, is ideally deliverable via the ambulatory care model (again in clear contrast with hospital care).

Saving the patient time and money is also a highly lucrative niche market for MIT Holding, as infusion medications typically require preparation by highly specialized pharmacy operations employing registered pharmacists, and the therapy itself is generally administered by a registered nurse or trained caregiver that ideally has established a good, long-term relationship with the patient.

A growing number of therapies are now deliverable in this fashion as well, making in-home treatment increasingly attractive to patients, and the option of going to a contracted ambulatory care center (the company operates one itself), staffed with full-time nurses and a doctor, in order to receive improved consultation, or assistance in obtaining reimbursement, is seen as a huge advantage to many patients and their families.

This is a big, growing market for MIT Holding, spanning such infusion therapies as total parenteral nutrition for chronic digestive and gastro-intestinal disorders, anti-ineffective therapies for diseases like chronic urinary tract infections, chronic pain management through intravenous or continuous analgesics, and a variety of others. In this same vein, the company’s DME sales and leasing capabilities, with access to a host of devices ranging from wheelchairs and oxygen concentrators, to nebulizers and other sustained-use equipment, provides MIT Holding with a constantly growing amount of Medicaid billing.

The expansion last year of the DME contract by WellPoint’s (NYSE: WLP) Georgia subsidiary, Amerigroup Community Care, to cover all of MIT Holding’s services (including ambulatory, infusion and perinatal), is a prime example of the company’s continually growing post-acute network footprint. Similarly, two contracts awarded more recently by HCIT and post-acute treatment patient transition innovator Curaspan Health Group, which maintains an impressive 98 percent customer retention rate, gave the company real-time access to market its compound pharmaceuticals, infusion services and DME offerings to the patients of over 5,400 Curaspan driven medical facilities nationwide.

The company’s deal with Coastal Carolina Medical Center is another good example here, in that the in-patient treatments MIT Holding was initially engaged to do dovetail exceptionally well with subsequent, more expansive ambulatory care service provisions, generating billing in the $1,000 per treatment range for the company.

With current approval by more than 130 insurance carriers for a variety of medical goods and services, as well as a much more focused core of operations specifically in the home health recovery space, MIT Holding has seriously tightened up its cost and revenue structure subsequent to its reorganization that began in 2011, and currently enjoys a 32 percent net profit standard on sales, services, and the like moving forward. Estimates of up to 90 percent savings for patients who utilize in-home infusion services will continue to be a major contributor to the company’s success, and with the U.S. home infusion market on track to grow 68 percent over the next five years to around $26.7 billion, MIT Holding will be looking to carve an ever-increasing slice of that pie off for its shareholders in years to come.

A continued focus on providing affordable, customer service-driven delivery of high-cost, low volume specialty infusions spells big profit for MIT Holding, and the requisite handling/administration requirements associated with such infusions will help the company maintain a firm grasp on the underlying market’s dynamics. And because MIT Holding handles all its own billing and collection practices via a sophisticated computerized billing framework, obtaining the lion’s share of its revenues from contracts with third party payers, affiliates and contractors, as well as self-pay patients and self-insured employers, the company has unprecedented fluidity when it comes to the claim review and editing process, as well as granular pre-service initiation control driven by rigorous insurance coverage verification and carrier authorization protocols.

For more information visit http://mitholdinginc.com/

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) – A Concierge Medical Service Provider Primed for Home Infusion Market

July 31, 2015

MITD logo

MIT Holding is a single source provider of concierge medical services and products throughout the United States. Through a portfolio of license, contractual and affiliate agreements, the company offers a portfolio of services that includes but is in no way limited to the:

• Administering of intravenous infusions;
• Management of medical services; and
• Provision of in-home therapies.

In a press release dated April 27, 2015, the company revealed that it had achieved positive net income from its operations in 2014, to the tune of over $14,000. This profit amount signaled significant improvement from the previous year’s numbers. It’s also a direct consequence of the company’s renewed focus on its in-home health recovery business and the resulting growth in overall income generated in 2014 (over $1.1 million).

Many aspects of the structure of MIT Holding’s in-home health recovery business, which facilitates and assists patients from the time of their release from a hospital through to a full in-home recovery, were finalized in 2014. The target audience for the business have been determined to be those needing infusion for recovery.

With many infusion therapies costing more than $10,000 per patient, per year and many patients needing special counseling and education regarding their condition and treatment, there is certainly a market for the business.
The two most recognized names in the infusion sector, CVS Health Corp. (NYSE: CVS) and Walgreen Co. (NYSE: WAG), have established footprints into the home infusion market through a series of strategic acquisitions that highlight the growing demand for home infusion services. The usual retail pharmacies and traditional distributors are generally designed to carry inventories of low cost, high volume products, while MIT Holding’s platform is based on the delivery of high cost, low volume specialty pharmaceuticals that have specialized handling and administration requirements.

Today’s United States home infusion market has been estimated at around $16 billion and is forecasted to reach approximately $27 billion by 2020, according to Harris Williams & Co. At a compound annual growth rate of approximately 9% per year, this could mean a significant market opportunity for MIT Holding. Furthermore, the company is anticipating that the demand for low cost, high quality home care will increase as paying patients become aware that they could realize up to 90% in savings on infusion services performed in the home versus in the hospital and that, as a result, this will result in continued growth for its in-home health recovery business. It is little wonder that this is an area of significant focus in its operations.

For more information, visit the company’s website at www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Offering High Quality Care at Reduced Costs through Home-Based Recovery Options

July 23, 2015

MITD logo

MIT Holding specializes in providing value-based healthcare options anchored by a commitment to strong customer service, excellent quality of care and improved quality of life for patients. In particular, the company is a trusted provider of home-based infusion services, enabling access to an expansive medical market. According to a report by Harris Williams & Co., the United States home infusion market is currently valued at $15.9 billion and is expected to grow to $26.7 billion within the next five years. This market growth is projected to come as payers continue to recognize the significant financial benefits of performing infusion services in the home, which can provide as much as 90 percent savings over those performed in a hospital setting.

“Our in-home health recovery business, which facilitates and assists patients from the time of their release from a hospital through to a full in-home recovery, is now in place,” Tommy Duncan, president of MITD, stated in a news release. “Our target audience is focused on those needing infusion for recovery.”

Currently, a large population of the potential home infusion market is being forced to visit hospitals in order to receive vital care. This is because of outdated Medicare guidelines that block payment for infusion drug patients that are treated at home. As a result, some patients are forced to endure daily hospital visits, costing the government an extra $585 million, according to the Department of Health and Human Services. However, these issues could be nearing a resolution.

In January, the Obama Administration announced plans to transition more than $100 billion in annual Medicare costs into value-based contracts designed to curb spending growth without reducing quality of care. This plan could be great news for MITD, as the company continues to realize strong market growth within the national healthcare industry. In 2014, MITD demonstrated its growth potential as it recorded an increase of more than $1.1 million in net income from operations.

As the national healthcare industry continues its shift toward value-based care, MITD is in a strong strategic position to promote sustainable growth moving forward. For prospective shareholders, the company’s proven home care services could provide a platform for favorable returns in the months to come.

For more information on MIT Holding, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Filling Unmet Medical Needs with Direction from Experienced Management

July 13, 2015

MITD logo

Thanks to advances in medicine and technology, people are living much longer these days. For many people, this longevity creates an increasing need for proficient at-home care for the highest quality of life, as well as for full recovery following discharge from a medical facility. Selecting a healthcare provider specializing in home-based services can be troublesome and place heavy burden on patients and families. MIT Holding has a simple solution powered by a forward-thinking, visionary management team.

MIT Holding is a single source of high-quality, low cost need-fulfillment for patients provided during their at-home recovery. The company works through its growing network of accredited agents, facilitators and contractual obligations to operate as a single-source provider of professional outpatient medical care including pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies, in addition to home medical equipment for sale or for rent.

The company also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Furthermore, as an accredited healthcare provider, MIT is in full compliance with major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators.

Spearheading this first-of-its-kind business model is a management team of qualified individuals with a shared vision to keep the company at the front-edge of in-home services.

Walter H.C. Drakeford, MIT Holding’s chairman of the board of directors and chief executive officer, has a stellar career that includes the senior managing director of Drakeford & Drakeford for the past 20 years. Since 2007, he has been the director of mergers and acquisitions of AMC Global Communications, Inc. He has also served as chairman of the board for Ebank Financial Services, and has served on the boards of Netstar-USA Corp. and LaidLaw Transportation. Drakeford also served as an attache to the White House under former presidents Nixon, Reagan and George H.W. Bush.

CEO Drakeford began his career with a finance degree from the University of Berlin and a Masters of Business Administration from Heed University, as well as a law degree from Thomas Jefferson School of Law.

Company CFO Robert Yates in 2008 joined MIT Holding as controller. Since 1987, Yates has served as controller or chief financial officer in small-to-medium size firms in Northern California. He received his accounting degree from San Jose State University in 1978 and gained his accounting and auditing experience with Arthur Young & Co. in San Jose, California. Yates obtained his license as a Certified Public Accountant in 1980, and is a veteran who served in the U.S. Air Force in the Vietnam era.

Tommy J. Duncan, president of MIT Holding, became a member of the company’s board of directors in May 2007, and joined the board of directors of Medical Infusion Group in September 2006. Duncan is employed with Southeast Vending, LLC, where he has been president since 2001. He has also been president of Southeast Lumber and Construction, Inc. since 2001.

MIT Holding believes that Duncan has the experience, qualifications, attributes and skills necessary to serve on the board because of his experience in finance, his having provided leadership and strategic direction and knowledge of the company and its business.

Together, this team of professionals has introduced to the healthcare market a much-needed and first-of-its-kind business model that adheres to the changes of the Affordable Care Act and provides patients with unparalleled in-home recovery services.

For more information visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Benefits from Requirements of Documentation and Value-Based Healthcare Options

July 6, 2015

MITD logo

The healthcare industry is in the midst of a substantial shift away from traditional fee-for-service payments, which have historically been associated with excessive and unnecessary care, in favor of value-based options. In January, the Centers for Medicare and Medicaid Services reaffirmed this fact when it announced a goal of having 50 percent of all Medicare payments in alternative payment models by the end of 2018. MIT Holding, Inc. (OTCQB: MITD), a leading provider of post-acute care nationwide, is in a strong position to capitalize on this evolving mindset by providing ambulatory care, in-home intravenous therapies, medical equipment and other recovery needs to help patients avoid unnecessary doctor and hospital visits.

According to a report by Fox Business, the total reduction in overall healthcare spending as a result of ambulatory surgery and therapy options amounts to approximately $2.6 billion annually, and an additional $2.4 billion in savings could be realized if just 50 percent of eligible cases were moved to these non-hospital settings. For MITD, these potential savings could translate into improved financial returns in the coming months. Demand for the company’s low cost, high quality home care is expected to rise as payers realize up to 90 percent savings on infusion services performed in the home instead of the hospital.

The potential market for MITD’s home infusion services is vast. According to Harris Williams & Co., the United States home infusion market is currently valued at $15.9 billion, and continued growth is expected to push the market to $26.7 billion by 2020. In the first quarter of 2015, the company made significant strides toward maximizing its share of this pivotal sector by recording just under $490,000 in consolidated revenues, which was a year-over-year increase of over 133 percent. Leveraging an increase in referrals and the strategic use of subcontractors, MITD also realized a gross profit of nearly $278,000 for the period.

“Our target audience is focused on those needing infusion for recovery,” Tommy Duncan, president of MITD, stated in a news release. “Our platform is based on the delivery of these high cost, specialty pharmaceuticals that have specialized handling and administration requirements.”

For prospective investors, MITD’s strong financial results in recent quarters, as well as the increasing demand for its value-based services, could provide the company with a platform to deliver strong returns moving forward. Look for MITD to continue building on its established position within the ambulatory care market in order to capitalize on rising demand in the years to come.

For more information on MIT Holding, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding’s (MITD) Single-Source Outpatient Care Model Driven by Cost-Effective Services, Custom Pharmaceuticals, Medical Supplies

June 18, 2015

MITD logo

The continually evolving healthcare market presents significant challenges for sector operators; not only when it comes to complying with the latest regulatory demands, but the complex logistical realities of patient care as well. MIT Holding (OTC: MITD) has assembled a unique mix of offerings that allows it to act, via a growing portfolio of contractual and affiliate agreements, as well as key licenses, in the role of a single-source provider to a variety of outpatient service and other markets. One of the most important relationships established by the company is with the originator of automated, on-demand online referral packets, Curaspan Health Group. Curaspan, a recognized Health Information Exchange and Patient Transition software company that helps connect providers, payers and suppliers through secure patient-transition network technologies and assists patients through their transition between different phases of care, is an important ally for MIT Holding’s ability to deliver winning solutions across the aforementioned markets, which are rapidly expanding as more and more people realize the benefits of outpatient care.

Markets like in-home infusion therapy, or the administration of medication through (typically) injection or catheter, is one of the top service areas enabled by MIT Holding’s contract with Curaspan. In-home infusion therapy has proven to be as safe and effective as inpatient care across for many diseases, is more convenient and comfortable for the patient, and generally results in better care and patient outcomes.

The contract provides MIT Holding access to a real-time market consisting of the patients from over 5,400 Curaspan affiliated medical facilities. By sending out a registered nurse to consult with the patient, conduct the administration of infusion care, help establish the patient’s medication and equipment needs in greater detail, as well as make determinations about any follow up appointments, additional therapy, or billing and insurance, MIT Holding is able to establish tightly-knit relationships and a stable commercial footprint.

Furthermore, MIT Holding – which specializes in providing an entire menu of such in-home recovery services and even operates ambulatory centers in Georgia through its subsidiaries – liaises directly with customers and is able to establish meaningful contact before the patient even leaves the healthcare facility. This personal contact allows the MIT Holding representative to map out a comprehensive home recovery template tailored to the individual.

With direct contact and MIT Holding’s tailored approach, outpatient care becomes an easy option for the end user, even before the cost savings over staying in the hospital have entered the equation.

The in-home infusion segment of the outpatient market alone is headed steadily upward from the $15.9 billion seen last year and is expected to reach a global market of over $26.7 billion within just the next five years (Persistence Market Research), growing at a CAGR of around 9.0 percent on the strength of increasingly aged populations around the globe, and increasing incident rates of chronic diseases which require infusion therapy.

This is particularly true in North America and Europe, infusion therapy’s two largest markets, where antibiotics and anti-infective indications represent the mainstay for major sector players like Baxter (NYSE: BAX) and CareFusion (NYSE: CFN), and are set to outpace the underlying infusion therapy market by around 0.8 percent CAGR over the same interval.

By 2050, 19 percent of the U.S. population will be over the age of 65; the incidence rate of chronic conditions is expected to follow suit, with estimates that over 170 million Americans will suffer some form of chronic disease by as early as 2030 (Harris Williams & Co.).

At the same time, the Patient Protection and Affordable Care Act (ACA) will continue to bring huge numbers of previously uninsured patients into the market. With nearly 11.7 million of the previously forecast 32 million uninsured set to be covered under the ACA already added to the rolls in state and federal marketplaces as of March 2015, according to Health and Human Services Secretary Sylvia Mathews Burwell, we are already starting to see the leading edge of this massive trend. The implications for outpatient care could be enormous.

For an in-home comprehensive health recovery services company like MIT Holding, this underlying phenomenology will continue to be a growth driver for many years to come, undergirding the company’s business model with a firm foundation that will only increasingly seek out the convenience and savings benefits its service offerings can provide. Taking care of the patient’s needs from hospital discharge through to recovery, and yet being able to provide as much as a 90 percent savings over equivalent care if it took place in a hospital setting, is a key factor that will continue to fuel MIT Holding’s revenue fire, helping the company extend the success of a profitable 2014. First quarter 2015 revenues were double that of the year prior.

The company also rents and sells robust medical equipment for the home, a market on track to hit $12.6 billion by 2018 in the U.S. alone, according to a study published last year by market analysts Freedonia, growing at a CAGR of 8.2 percent from the roughly $8.5 billion seen last year. The increase in chronic diseases like cancer, kidney failure and respiratory disorders will be a major contributing factor to rising demand for hardware like oxygen concentrators needed for COPD (chronic obstructive pulmonary disease) and the like.

Another key advantage MIT Holding has is access to specialty drugs and custom compound pharmaceuticals, allowing the company to cost effectively address the medicinal needs of its patient customers and offer compelling availability/affordability advantages. With the specialty pharmaceuticals market at over $78 billion last year (Drug Channels Institute), MIT Holding is in a prime position to compete with the 250 plus URAC-accredited (Utilization Review Accreditation Commission) specialty pharmacies out there (including about 100 “In Process” companies expected to achieve accreditation this year), possessing an established customer pool that is built on comprehensive services and face-to-face contact. The company also distributes wholesale pharmaceuticals in the U.S. and overseas via its subsidiaries.

With MIT Holding and its affiliates now able to direct bill and receive payments from over 138 of the country’s top regional and national carriers on behalf of patients, carriers like Medicare/Medicaid, as well as major players like Aetna (NYSE: AET) and Cigna (NYSE: CI), the company is now more confident than ever about its business model. The company leverages a model built on the medical and financial benefits of a smooth patient transition that takes them all the way through from their discharge at the hospital to recovery within the comfort and familiarity of their own home.

Learn more by visiting the company’s newly overhauled website at www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Offers Unique In-home Infusion Experiences Utilizing Fully Licensed Compounding Pharmaceuticals

June 11, 2015

MITD logo

Los Angeles-based MIT Holding has an established working arrangement with one of the approximately 400 compounding licensed pharmacies remaining in the United States. Currently, many big name pharmaceutical companies are buying up these compounding pharmacies to eliminate competition. However, MIT Holding has a contractual arrangement with a well-respected and highly qualified compounding pharmacy that enables it to fulfill its own infusion and other specialty prescriptions. This capability provides MIT Holding with a distinct advantage over local “mom-and-pop” infusion centers in the rapidly growing $11 billion a year U.S. infusion therapy market.

The two most recognized names in the infusion sector are CVS Health Corp. (NYSE: CVS) and Walgreen Co. (NYSE: WAG). Both of which have established footprints into the home infusion market through a series of strategic acquisitions that highlight the growing demand for home infusion services.

CVS earlier this year completed its acquisition of Coram LLC, the specialty infusion services and enteral nutrition business unit of Apria Healthcare Group Inc., and in May entered into a definitive agreement to acquire Omnicare (NYSE: OCR). The acquisition of Omnicare is expected to greatly expand CVS’s specialty pharmacy business and increase its ability to dispense prescriptions in assisted living and long-term care facilities.

MIT Holding is also uniquely positioned for opportunities in the prescription dispensary and in-home infusion services markets. That is because MIT Holding’s business model is built around the company’s full suite of in-home recovery services, which begins when MIT Holding sends a company representative to a patient’s hospital bed on the day of discharge to establish a blueprint for successful home recovery.

Following the initial contact, MIT Holding will send a registered nurse (RN) directly to the patient’s home to provide infusion therapies and consultation. The typical four-hour infusion procedure allows the RN to establish a personal working rapport and customized recovery regimen for the patient, while cross-marketing MIT Holding’s complete suite of services. The RN offers a thorough analysis of the patient’s needs, from medications, durable medical equipment, doctor appointments, therapy sessions, insurance billing, insurance inquires, and a financial overview of the expected expenses of the remaining recovery period.

With current MIT Holding patients, this cross marketing approach is effective by including all other household members. MIT Holding benefits with an immediate expansion of its patient base by offering its services to meet the medical needs of these family members. Results have shown that families and patients often realize valuable savings on their medications, including the original infusion therapies.

MIT Holding’s new approach establishes a digital databank of information on the patient’s recovery regimen, which was created at the bedside of the patient at the point of discharge. This creates a new revenue stream of vital records necessary for doctors and hospitals to comply with new mandatory federal requirements, documenting their patient’s recovery.

Through its innovative and comprehensive in-home recovery services, which include specialty drugs, infusion services, compounding pharmaceuticals, direct insurance inquiries, insurance billing, and cross marketing efforts, MIT Holdings is in prime position to take advantage of multi-billion dollar markets. Based on IMS Health data, the specialty pharmaceuticals market is valued at $77.5 billion, constituting roughly a quarter of the overall market and growing at more than double (8.8%) the rate. Combined with the $11 billion home infusion market, these sectors are rapidly approaching the $100 billion mark.

For more information visit www.mitholding.com or contact William Nalley at 305-515-8077

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc.’s (MITD) Unique Healthcare Solution Solves Some of the Industry’s Greatest Challenges

June 9, 2015

MITD logo

The Health Information Technology for Economic and Clinical Health Act (HITECH) of 2009 establishes programs under Medicare and Medicaid to provide incentive payments for the use of certified electronic health records technology. Though these Meaningful Use Rules (MUR) were designed to improve healthcare outcomes by utilizing Electronic Health Records (ERH) and documentation, there’s an ugly side of the program that has left many healthcare providers scrambling to adhere to the documenting standards of MUR. The good news is, small-cap innovator MIT Holding, Inc. (OTC: MITD) has the solution providers need to comply.

As of January 2014, 20 different rules for doctors and 19 different rules for hospitals became mandatory under stage two of MUR. Medicare and Medicaid providers are now required to document a patient’s recovery after they are released from care. Gathering this information can be tricky. Some documentation, such as age, weight and gender, is easy to obtain. In-depth follow-up such as checking that the patient is properly taking their medication and following doctor’s orders for and rehabilitation, however, can be time intensive, hard to fill, and is at mercy of the patient’s truthfulness.

If the patient does not recover or the healthcare provider fails to properly document the recovery, the provider will be penalized in that Medicaid/Medicare will pay all of those same procedures billed for the next year at a lower payout. For example, if a hospital bills Medicare/Medicaid $10,000 for a procedure and the hospital does not provide the proper after-care documentation, the hospital is subject to penalty by Medicare/Medicaid. So if the penalty is 10%, the hospital would only receive $9,000 for that procedure over the course of the next 12 months.

This structure can have a dramatic impact on doctors and hospitals that lack the means, resources or the know-how to meet standard reporting. While healthcare providers can easily purchase the software and information technology (IT) needed to report the documentation, they still haven’t found a fully efficient way to gather the information. In fact, Frost & Sullivan reports that more than 50% of healthcare providers lack a plan of action to implement the health IT needed to improve care efficiency.

Managed Healthcare Executive recently published an article discussing the strategies and struggles of some of today’s leading care companies as they work to meet the new requirements. According to the article, Cigna Corp. (NYSE: CI), Aetna, Inc. (NYSE: AET), and Humana, Inc. (NYSE: HUM) utilize accountable care organizations (ACOs).

Cigna’s strategy, for example, is to execute patient outreach through the use of an “embedded care coordinator” with an ACO provider group. The company trains nurses, provides information on at-risk patients, and then informs nurses of which patients are being discharged from the hospital. The nurses then calls the patients at their home the day after their discharge to answer medical questions, confirm additional appointments, and keep patients educated on what to expect during recovery.

MIT Holdings’ solution offers doctors and hospitals the ability to refer their patients to the company’s comprehensive, one-source recovery service built on face-to-face patient contact. This first-of-its-kind service starts as soon as the patient is discharged from the hospital, at which time MIT assumes the responsibility of the recovery period. By building a personal relationship with the patient in the comfort of their own home, MIT has the unique ability to gather important information to meet MUR mandates.

If Cigna were to employ MIT’s solution, here’s how it would look: Cigna would be able to eliminate the expense and bureaucracy of the embedded care coordinator by eliminating the role altogether. Instead, MIT would meet with the patient at the time of discharge and if necessary would even accompany the patient home and help them determine each and every recovery need. MIT would also meet with other members in the household, and for the patient as well as those members would price pharmaceutical needs through the MIT pharmacy. Through this process, MIT, on behalf of Cigna, would establish a relationship with the patient that would promote clear and accurate communication, feedback and documentation. MIT is even capable of handling billing and insurance issues.

“We handle all the billing and all of the medical needs that an individual will need, and our record keeping will be through in-home interaction with the patient and will contain all of the information that Cigna, Aetna or Humana would need to report for the MUR,” explains William Nalley, IR representative for MIT Holding.

From the time of patient discharge from the medical facility, MIT’s services handle everything pertaining to the at-home recovery phase, including in-home medical equipment, infusion services, medications, follow-up appointments, organize therapy sessions, wound dressings, transportation, insurance inquires and professional insurance claim billing.

The goal is to make the patient feel like their care provider went home with them – there is no lapse in patient care or communication. All the patient needs to do is follow the MIT professional health caregiver’s instructions and recover while MIT documents the recovery of the patient, interacting with them one-on-one to help them properly, efficiently and quickly heal.

The digital paperwork MIT maintains in order to monitor the patients recovery contains all the information the hospital and doctors need to comply with the new rules. By recognizing the steep implications hospitals may face under the new requirements and developing a tested and sound solution, MIT has the potential to revolutionize the way doctors and hospitals gather and report patient recovery progress.

As more healthcare providers become aware of these services, MIT is catching wind in its sail, and recently reported first-quarter revenues of $489,854, more than double prior-year first-quarter revenues of $279,872. The company attributes this growth of 133.3% to an increase in customer referrals and subcontractor services. The first-quarter net loss of $9,654 represents a drastic cut from a loss of $105,726 a year ago. This resulted in a gross profit for the first quarter of $277,922, or 56.7%, as compared to gross profit for the same quarter in 2014 of $127,790, or 60.9%.

Moving forward, MIT will continue to market its comprehensive at-home recovery solutions and services as a viable solution to the healthcare industry’s growing demands.

For more information visit http://mitholdinginc.com/investors.html or contact William Nalley at 305-515-8077

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Embraces The Affordable Care Act while Others Push Back, Achieves Better-than-Expected Q1 Results

June 2, 2015

MITD logo

MIT Holding saw its business grow above expectations in the first quarter, reporting triple-digit increases in revenues, service income and gross profit, and a drastically reduced net loss. The source for such incredible year-over-year growth? The company’s acceptance and adaptation to the Affordable Care Act (ACA).

While many companies have pushed back against the ACA, MIT Holding embraces the new healthcare law. Anything new means a change to the old ways of doing business. Fight the changes and you have a host of new problems to deal with on a daily basis. Change what you were doing, however, and those problems just seem to disappear.

Meaningful Use Rules under the ACA requires doctor and hospitals to document a patient’s recovery after discharge. This mandate creates significant obstacles for hospitals, such as how to track a patient’s recovery while they are at home and how to ensure they are taking the proper medications, therapies, and keeping multiple appointments. These challenges are sending hospitals nationwide scrambling to find a solution for these MUR requirements.

How serious is this to doctors and hospitals? Very. For example, let’s say a hospital bills Medicare/Medicaid for procedure “XYZ” and the allocated payment for that service is $10,000. The hospital must now follow up on the patient AFTER discharge.

Should the patient not recover or the hospital not properly document according to the rules, the hospital is penalized for the next year in that Medicaid/Medicare will pay all of those same procedures billed for the next year at a lower payout. So if the penalty is 10%, the hospital would only receive $9,000 for procedure “XYZ” for the NEXT 12 MONTHS.

Recognizing the steep implications hospitals may face under the new requirements under the ACA, MIT has developed a solution. MIT offers doctors and hospitals the ability to refer their patients to the company’s one-source recovery service. This first-of-its-kind concierge service starts as soon as the patient is discharged from the hospital, at which time they are met with an MIT representative. With the patient’s permission, MIT then assumes the responsibility of the recovery period.

MIT’s services are comprehensive to the at-home recovery phase, handling everything from in-home medical equipment, infusion services, medications, follow up appointments, therapy sessions, wound dressings, transportation, insurance inquires and professional insurance claim billing. The company’s goal is for the patient to feel as if the hospital went home with them. There will be no lapse in care. All the patient needs to do is follow the MIT professional health caregiver’s instructions and recover. On a daily basis, MIT will document the recovery of the patient, interacting with them one-on-one to help them heal properly, efficiently and quickly.

The digital paperwork the company maintains in order to monitor the patients recovery contains the information the hospital and doctors need to comply with the new rules. For a small and reasonable fee that information is now an email away.

With this solution, MIT has answered the question many hospitals are asking: “How do you track a patient once they have left the medical facility?”

When a pneumonia patient is discharged from the hospital and signed onto MIT’s system, the company expects that on average there will be from $12,000 to $15,000 in billable events. The company is prepared to capture those events and collect a fee for the digital paperwork documenting the recovery. A simple integration of the hospital software with MIT’s software should deliver that information in a format ready for filing with Medicare/ Medicaid.

The efficiency and growing popularity of MIT’s one-source solution is in the numbers.

In a recent 10Q filing, MIT reported first-quarter revenues of $489,854, more than double prior-year first-quarter revenues of $279,872. The company attributes this growth of 133.3% to an increase in customer referrals and subcontractor services. The first-quarter net loss of $9,654 represents a drastic cut from a loss of $105,726 a year ago. This resulted in a gross profit for the first quarter of $277,922, or 56.7%, as compared to gross profit for the same quarter in 2014 of $127,790, or 60.9%. Furthermore, new billing procedures improved the company’s accounts receivable by nearly 200%.

Moving forward, MIT will continue to embrace the ACA and the opportunities it provides for the company’s at-home recovery solutions and services.

“We deal in solutions not problems at MIT Holding and see no reason to fight the system,” says William Nalley, head of MIT’s investor relations. “When the problem occurs for the doctors and hospitals MIT Holding deliver the solutions. The benefit for MIT Holding is the captured billing events for that patient’s medical recovery.”

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Initiates Awareness Campaign with Upcoming Investor Luncheons

May 26, 2015

MITD logo

New investor eyes. That’s what every publicly traded company needs. News releases, social media and articles are a great away to attract investor attention, but a company with substance still places a great value on face-to-face meetings with brokers, investment bankers and most importantly existing and potential shareholders.

Los Angeles-based MIT Holding is a provider of a professional one-source total recovery system that takes a patient from the hospital bed through full recovery. The company takes the responsibility of medications, appointments, the endless calls to the insurance carriers, home visits and, most importantly, the burden and stress of being sick and depending on family and loved ones.

MIT Holdings is gearing up for multiple investor luncheons scheduled for this summer. The luncheons will last approximately two hours and offer attendees one-on-one interaction to hear the full MIT Holding story and receive answers to any lingering questions.

“Even though just about every person alive can relate to our services and business model, because we are the first to create or pioneer this niche in the industry, it takes a little extra personal time to make sure the investor realizes what we have in fact created,” says William Nalley, IR consultant for MIT Holding. “We have reorganized the company and given our shareholders, for the first time, a self-sustaining business that needs no outside funding for day-to-day growth and an organic 25% year-over-year growth.”

Further explaining the business model, Nalley explains, “Think about it; anyone who has ever been through or has had a loved one go through a critical illness and attempt to navigate through the recovery period by themselves would give an arm and a leg to have one company to go to and say, ‘Here is my illness; this is what I need; take care of it!’ Well, we go one step further and meet with you in the hospital prior to discharge and start taking care of it at that moment. We go home from the hospital with you, so all you need to focus on is recovery.”

In support of its core services, MIT Holding also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Your doctors, your medications and your hospitals will change throughout your life; MIT Holding will not. The company stays with its patients through the rest of their life, taking care of any medical needs that arise.

Combined, these services contribute to MIT Holding’s strategy to provide custom prescription solutions, maximize cross marketing, and generate multiple revenue streams.

MIT Holding has priced its services to achieve 32% minimum net profits and has maintained operational profitability in its fiscal third and fourth quarters, validating the company’s business model, its adaptable approach to the Affordable Health Care Act, and its potential in the health services industry.

Because MIT Holding meets and/or exceeds major U.S. health insurance requirements, the company can direct bill and receive payments from more than 128 carriers, Medicare and Medicaid on behalf of the patient its agents and its facilitators. This is an important component in the company’s goal of developing the first-of its-kind seamless transition for patient needs from hospital discharge to complete home recovery.

The ultimate desired outcome for meeting with brokers and shareholders is to raise brand awareness and transparency, and thereby potentially increase volume and liquidity.

“Once we increase those two factors, we become a different story. These luncheons are just another way to explain our business model and gain momentum,” explains Nalley. “Our intention is to do a year-long, nationwide investment/broker campaign. We’re going in and shaking the hands of brokers and making MIT Holdings management available for questions now and down the road.”

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Reaps Strong Benefits from Corporate Reorganization Efforts

May 4, 2015

MITD logo

Since its establishment in 2006, MIT Holding has made major strides in expanding its healthcare service line. In addition to offering services to its patient base that includes home medical equipment, an ambulatory center and a compounding pharmacy, the company’s specialized educational programs have laid the foundation for more successful treatment throughout its operating region. Programs including healthcare professional training, clinician education programs, home infusion processes and emergency preparedness tips have allowed MITD to establish close relationships with healthcare providers and patients in the area, providing a significant foothold in a fragmented niche of the industry.

According to the company’s recent financial reports, its growth strategy is working. For full-year 2014, MITD achieved positive net income from operations of $14,152 compared to a loss of $1.12 million for the 12 months of 2013. MITD attributes the swing to its successful reorganization and renewed focus on its home health recovery business.

“Our in-home health recovery business, which facilitates and assists patients from the time of their release from a hospital through a full in-home recovery, is now in place,” Tommy Duncan, president of MITD, stated in the news release. “This was an area of significant focus in our restructuring efforts and which led to our financial turnaround in 2014. We look for continued growth in this business in 2015 and beyond.”

To satisfy the need for additional revenue streams moving forward, MITD has focused on the assembly of a strong portfolio of licenses, contracts, agreements and working arrangements designed to create a ‘one-stop-provider’ of services for patients in transition between inpatient and outpatient care. With the health care system continuing to push for quicker patient discharges, the company is strategically positioned to fill the gap in an environment that now places much of the responsibility throughout the recovery process on the shoulders of patients.

“Our goal is to ease this burden and create for patients a single source for all of their necessary medical products and services. We want to care for the patient for the rest of their lives, for any future medical needs” said Duncan.

As the company continues to make strides towards establishing itself as a leader in medical and technological innovations designed to enhance the quality of life of patients, look for continued growth in the rapidly changing medical industry.

According to a report from Health Affairs, unsustainable costs is forcing the U.S. healthcare system to transform into a more outpatient, community-based model. With this trend in mind, MITD is in a strong position to grow its influence for years to come.

For more information on MIT Holding, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Achieves $1 Million Turnaround and Positive Net Income from Operations

April 27, 2015

MITD logo

Today before the opening bell, MIT Holding proudly reported that it has achieved positive net income from operations in 2014.

Last week the company filed a Form 10-K with the SEC showing a net income from operations of $14,152 in 2014 compared to a net loss from operations of ($1,123,830) for the same period a year earlier. The company attributed this dramatic change to the company’s overall restructuring efforts and renewed focus on its in-home health recovery business.

“Our in-home health recovery business, which facilitates and assists patients from the time of their release from a hospital through to a full in-home recovery, is now in place,” commented Mr. Tommy Duncan, President of MIT Holding. “This was an area of significant focus in our restructuring efforts and which led to our financial turnaround in 2014. We look for continued growth in this business in 2015.”

Demand for low cost, high quality home care will only increase as payers realize up to 90% saving on infusion services performed in the home versus in the hospital. According to Harris Williams & Co, the United States home infusion market is $15.9 billion and is expected to reach $26.7 billion by 2020, resulting in a compound annual growth rate of 9.02% per year.

Mr. Duncan further commented, “Our target audience is focused on those needing infusion for recovery. Many infusion therapies cost more than $10,000 per patient, per year. Patients receiving treatment usually require special counseling and education regarding their condition and treatment. Retail pharmacies and other traditional distributors generally are designed to carry inventories of low cost, high volume products. Our platform is based on the delivery of these high cost, low volume specialty pharmaceuticals that have specialized handling and administration requirements.”

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Innovative Healthcare Model Boasts Tri-Fold Effect

April 10, 2015

MITD logo

MIT Holding has carefully established a network of agents, facilitators and contractual obligations through which it believes is the opportunity to greatly enhance the healthcare industry. The Los Angeles-based company is a single-source provider for medical recovery services, specifically for the fourth and fifth phases of medical recovery: the dependent patient and recovery/rehabilitation stages.

Here’s how it works. An MIT representative meets with the hospital discharge planner and patient on the day of the patient’s discharge from the medical facility. This representative takes full responsibility in arranging in home or local clinic appointments, medication, medical equipment needs and insurance approvals for the patient, enabling them to focus on the recovery at hand without additional stress. In most cases, the products and services offered by MIT are already pre-approved by the patient’s health insurance, which enables the company to directly bill and receive payments from carriers on behalf of the patient as well as company agents and facilitators.

The company’s current line of services includes professional outpatient medical care such patient pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies. In addition, durable medical equipment services (DME) enable the company to offer for sale or rent, home medical equipment, from crutches to hospital beds.

MIT also offers legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; and travel and transportation services of medically challenged patients for medical needs and personal travel.

Need for these services arise from pressure for doctors and hospitals to lower costs, which results in patients being released from the hospital earlier to reduce the cost of care.

By offering a complete need-fulfillment for the patient during their at home recovery period, MIT’s services assists the patient through recovery, helps healthcare facilities lower their costs, and creates opportunities to cross market its goods and services to enhance revenues streams.

Following a successful reorganization initiative launched at the start of last year, MIT is now positioned to achieve 32% minimum net profits and maintain profitability. This profitability validates the company’s business model and its approach to the evolving health services industry.

According to the latest figures from the Centers for Disease Control (CDC), in 2013 more than 35 million patients were discharged after a nearly five-day stay in a non-federal hospital. The same year, outpatient services exceeded 100 million patients in non-federal facilities. Based on these figures, MIT is tackling a market opportunity of more than 135 million patients to which it can cross market its invaluable products and services while working toward its broader mission to lead medical and technological innovations to enhance the physical, emotional and aesthetic quality of life.

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Well-Positioned to Continue Racking Up Profitable Quarters as Healthcare Industry Transitions from Inpatient to Outpatient Care

April 1, 2015

MITD logo

There has been a gradual but consistent shift in healthcare over the last decade or so from inpatient stays to ambulatory care (outpatient care) and the advent of the Patient Protection, as well as the Affordable Care Act (ACA), have accelerated this transition in the overall healthcare business model substantially. According to healthcare advisory firm Kaufman Hall, inpatient utilizations (per 1k) continually declined from 2000 to 2011 and 71% of the states in their study showed decreases of over 5%. A clear trend which is further evinced by Fitch Ratings’ report from August of 2014 showing a marked decline in inpatient activity and a corresponding rise in ambulatory care in their sweeping rated hospital and health system portfolio.

Some of the core reasons behind this transition are a growing focus on risk-sharing arrangements and coordinated or collaborative care, as well as the increasingly prominent financial benefits of value-based payment models, particularly under the ACA, which has optimized the playing field for low-cost, high-quality service in the most convenient settings for the patient. With Medicare providing coverage to some 54 million seniors last year, totaling $615.9 billion (including beneficiary premiums) and the number of those covered set to rise sharply within the next 15 years to around 81.4 million, as Baby Boomers continue to retire in droves, a perfect storm is brewing in the outpatient care services market. Total expenditures on healthcare in the U.S. for 2014 ran around $3.09 trillion, or 18% of GDP and these costs are projected to rise 15.5% by 2017 to over $3.57 trillion, making the future for service and product providers, particularly those who can master the rising trend towards ambulatory care, a very bright one indeed.

One of the larger hospital and home care agency focused providers in the U.S., Community Health Systems (NYSE:CYH), serves as an excellent benchmark for the ongoing transition to ambulatory care, with total associated revenues up around 1% year over year to 55.8% in 2014. Other large hospital operators, like HCA Holdings (NYSE:HCA) and Tenet Healthcare (NYSE:THC), also saw large chunks of their bottom line attributable to ambulatory care last year, at around 38.4% and 36.2% of revenues respectively. South Nassau Communities Hospital (Oceanside, NY) is another good benchmark here, with a 62% to 38% inpatient to outpatient mix only five years ago, having shifted to a 59% to 41% mix as of last year. COO and Executive VP of Administration for the hospital indicated that their experiences were consistent with the broader industry trend and that the drive to improve outcomes and service in a cost-effective manner was a major priority as South Nassau Communities Hospital as they transitioned more and more of their overall care footprint from the hospital to the community.

One of the exciting up and comers to provide an innovative approach amid this growing trend is MIT Holding (OTCQB:MITD), which has developed a portfolio of products and services ranging from custom compound pharmaceuticals and a wide variety of sold/rented home medical equipment, to IV infusions, ambulatory/in-home therapies, and medical management services. The company has emerged after a profile build up and reorganization to post back-to-back profitable quarters (as of Q2 2014) on the strength of several significant new revenue streams, including two key contracts with the first company to automate the patient transition process, Curaspan Health Group, whereby MITD can market their products and services directly to patients of Curaspan’s 5.4k plus medical facilities.

As of the start of last year, MITD revenues were on-track for a 32% net profit baseline and the company is pricing future business on that basis. One of the new revenue streams, a sub-investigator role (via the company’s facilitators) initiated back in November of 2014 for the main investigator in a Phase 3 study evaluating treatments for complicated bacterial and soft tissue infections, Melinta Therapeutics, not only validated the company’s approach to landing more business in this lucrative and highly specialized market, it opened the door for expansion of the contract on this 12-month study featuring two to four hour patient infusions and came with a 52% gross profit margin. Growth opportunities like the sub-investigator role in the Melinta study matches the company’s business model. MITD’s approval by over 130 insurance carriers goes a long ways towards helping to cement the company’s role as a chief sub-investigator. The Melinta study highlights a now established and growing presence in this highly profitable space for MITD.

Take a closer look at the company by visiting www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Pioneers Single-Source Approach to Revolutionize Outpatient Medical Home Medical Care

March 24, 2015

MITD logo

Los Angeles-based MIT Holding, operating through its network of accredited agents, facilitators and contractual obligations, has developed a single-source approach geared to simplify professional outpatient medical care for the roughly 135 million people discharged from inpatient hospital care in the U.S. each year.

The company provides a comprehensive set of outpatient services designed to accelerate patient recovery by providing them with ultimate convenience and by reducing stress associated with coordinating and receiving appropriate products and care. MIT’s services are provided within the comfort of the patient’s home and include ambulatory infusion therapies, home infusion services and medical equipment delivery.

Additionally, because MIT is in compliance with major U.S. health insurance requirements, the company is able to direct bill and receive payments from carriers on behalf of patients, agents and facilitators. The result is a seamless transition for patient needs from hospital discharge to complete home recovery.

MIT has completed beta tests on its single-source concept, successfully providing medical recovery services from the point of discharge from the hospital or medical facility to full recovery. The company’s initiative is to use the testing as a catalyst to grow its presence nationwide and expand through one strategic acquisition per quarter.

In support of its core services, MIT also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act.

Demonstrative of the company’s flexibility and progressive insight to the healthcare industry, MIT also offers travel and transportation services of medically challenged patients for medical needs and personal travel. Furthermore, through its contracts, MIT is approved to conduct and administer FDA clinical trials.

Together, these services are the foundation of MIT’s mission to provide custom prescription solutions in a variety of methods while generating multiple revenue streams and increasing shareholder value.

Thanks to a strategic and successful reorganization initiative in 2014, MIT is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability underscores the company’s unique concept and its relevance to the health services industry.

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc.’s (MITD) Home Health Services Model is Complementary to Broader Medicare Goals

March 10, 2015

MITD logo

Nearly 14% of Medicare patients discharged to a skilled nursing facility (SNF) after a hospital stay are readmitted to the hospital for conditions that could have been avoided with better care, according to MedPAC analysis. A collaborative effort between the Partnership for Patients and the Center for Medicare and Medicaid Services (CMS) aims to reduce hospital readmissions by 20% and save the healthcare system tens of billions of dollars in upcoming years. MIT Holding has a complementary approach: a single source of high-quality, low cost need-fulfillment for patients provided during their at-home recovery.

Research shows that sufficient homecare recovery after a hospital stay can drastically reduce mental and physical stresses on the patient, minimize the length of recovery and associated costs, and reduce the risk of hospital re-admission and hospital acquired conditions.

MIT Holding has built its business model around this concept, and works through its growing network of accredited agents, facilitators and contractual obligations to operate as a single-source provider of professional outpatient medical care including pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies, in addition to home medical equipment for sale or for rent.

The company also provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Furthermore, as an accredited healthcare provider, MIT is in full compliance with major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators.

In June, 2014, MIT achieved its first profitable quarter in six years, and each company subsidiary is now operating with objectives of a 32% net profit. This profitability validates MIT’s approach to the evolving Affordable Health Care Act as well as the company’s impact on patient recovery and the broader healthcare industry.

MIT recently completed successful beta testing of its concept in Georgia and now plans to expand its first-of-its-kind approach nationwide via one acquisition per each quarter of 2015. The company’s broader business model is focused on building shareholder value, revenues and corporate expansion while providing viable solutions to the changing care sector.

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

Home Recovery Health Services Model by MIT Holding, Inc. (MITD) Features Cross-Marketing Advantages

February 27, 2015

MITD logo

The road to recovery can, but doesn’t have to, be a long, stressful and expensive one. Adequate homecare after a hospital stay can play a substantial role in reducing the mental and physical stresses on the patient, thereby minimizing the length of recovery, associated costs and reducing the risk of hospital re-admission.

Los Angeles-based MIT Holding has developed a unique approach to the fourth and fifth phases of medical recovery – the dependent patient and recovery/rehabilitation stages – by offering a complete need-fulfillment for the patient during their at-home recovery period following a medical event.

MITD’s single-source approach provides a personalized recovery period in which more patient information and recovery needs are discovered and efficiently addressed for the patient. Through its current portfolio of services, MITD can arrange for patient pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies. In addition, durable medical equipment services (DME) enable the company to offer home medical equipment, from crutches to hospital beds, either for sale or for rent.

By shouldering these components of the recovery process, this innovative concept greatly benefits the care provider and patient while allowing MITD to cross market its goods and services to the patient to enhance revenue streams.

The actual model is designed as such: an MITD representative meets with the hospital discharge planner and patient on the day of the patient’s discharge from the medical facility. The MITD representative alleviates patient burden by taking full responsibility in arranging in home or local clinic appointments, medication, medical equipment needs and insurance approvals. In most cases, the products and services offered by MITD are already pre-approved by the patient’s health insurance. MITD meets and/or exceeds major U.S. health insurance requirements, which enables the company to directly bill and receive payments from carriers on behalf of the patient as well as company agents and facilitators.

Until MIT Holding stepped into this space, there was virtually no single-source service provider of an all-inclusive product line of medical goods and services for this mandatory market.

As an example of how the model works, consider the fact that a patient recovering from a respiratory illness will typically require four-to-six weeks of recovery. In this case, ta patient’s visit usually requires a four-hour visit from a registered nurse (RN) to administer an intravenous infusion of antibiotics. During the visit the RN will review the patient’s prescription history and current medications. Any additional medications the patient or other family members are taking will be priced through MITD’s affiliated compound pharmacy and delivered directly to the home.

Insurance companies will normally pay for most items and services that will speed recovery. For example, patients with a respiratory illness are advised to sleep in a reclined position. The insurance company will not buy a hospital bed, but they are likely to cover the cost of a temporary rental.

When you consider the number of patients in need of at-home recovery assistance, it’s obvious why MITD is innovating in this market of the healthcare industry.

According to a CDC Report, in 2013 alone more than 35 million patients were discharged after a nearly five-day stay in a non-federal hospital. In the same year, outpatient services exceeded 100 million patients in non-federal facilities. These facilities normally have an insured or self-insured patient base.

Based on these figures, MIT Holding sees a nationwide market potential of more than 135 million patients annually to which it can cross market its invaluable products and services while working toward its broader mission to lead medical and technological innovations to enhance the physical, emotional and aesthetic quality of life.

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Offers Patients an Opportunity to Relax in Style

February 25, 2015

MITD logo

With advancements in medicine, technology and quality of life, people are, on average, living much longer these days than they ever have before. In an effort to further improve quality of life for its patients, MIT Holding, Inc. (OTCQB: MITD) partners with hospitals, physicians, facility based providers, pharmaceutical manufacturers and healthcare payers, through its portfolio of services, to provide post-acute care to patients nationwide. In addition to educational programs and in-home treatment options, the company offers unique travel ventures designed to dramatically improve its patients’ quality of life without creating unnecessary medical risk.

The MIT Holding’s Medical Sea Cruises program will offer individuals who require dialysis or infusion treatment the opportunity to travel abroad with family and friends without missing out on required medical care. The company’s commitment to the care of its patients is the foundation for its unique travel options. With dedicated and trained medical professionals readily available throughout their vacation, patients can relax in style without unnecessary fear of health-related complications.

The company’s travel programs open the door for thousands of patients whose travel may have been highly restricted in the past. According to reports from the Centers for Disease Control and Prevention, an estimated 29.1 million people, or 9.3% of the U.S. population, struggle with diabetes, which accounts for just over 38% of kidney failure cases throughout the country. As a result, nearly 230,000 people of all ages live on chronic dialysis, which can seriously restrict the opportunity for prolonged travel.

The company’s mission is to be the leader in medical and technological innovations created to enhance the physical, emotional and aesthetic quality of life of its patients. While MIT Holding continues to serve its patients throughout Georgia and South Carolina with high quality ambulatory care and home infusion services, few programs can compare to the potential to enhance the overall freedom and quality of life of patients presented by the company’s Medical Sea Cruises program.

For more information on MIT Holding, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc.’s (MITD) In-Home Medical Recovery Services Hold Potential for Future of Healthcare

February 20, 2015

MITD logo

Many successful innovations fulfill an unmet need, whether realized or not. Creation of these innovations stems from progressive thinking, a visionary mindset, and the powerful capability to properly plan and execute a strategy for the desired outcome. The healthcare industry’s bumpy road to change is pocked with numerous unmet needs, and MIT Holding is traveling this course to provide an innovative first-of-its-kind solution to pave over many of these needs.

MIT Holding is a single-source provider for in-home medical recovery services. Specifically, the company, through its portfolio of service agreements, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas. Need for these services arise from pressure for doctors and hospitals to lower costs, which results in patients being released from the hospital earlier to reduce the cost of care.

Focused on how present issues and solutions will greatly impact the future of healthcare, MIT Holding’s innovative platform has potential to be an integral component of industry change. The company’s concierge services meet the patient when they are discharged from the hospital and help them transition through complete recovery – in essence picking up where the hospital left off.

Backed by a visionary and aggressive management team, MIT Holding is in a prime position to duplicate its business model to the benefit of the company itself, hospitals seeking cost reduction, and patients in need of an assisted, stress-free in-home recovery. The company sees multiple cross marketing opportunities for its professional recovery services model to be implemented into the core of the healthcare recovery industry.

Following a successful beta testing of the model in Georgia, MIT Holding management is pioneering this new concierge concept to travel nationwide via strategic acquisitions. Aiming to achieve one acquisition per quarter, MIT Holding is seeking out accredited and profitable acquisition targets that will add value to the broader business model.

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

MIT Holding, Inc. (MITD) Introduces First-of-its-Kind In-Home Concierge Medical Service

February 11, 2015

MITD logo

Imagine you’re in the hospital, preparing to check-out the following day. Knowing the recovery ahead will require certain accommodations, you phone downstairs to the concierge desk and say, “I’m checking out tomorrow; would you please make all the arrangements for my recovery at home?”

If that doesn’t sound like the steps taken by you or a loved one following release from a hospital in the past, it’s because the service didn’t exist. Until now.

With MIT Holding’s patient-centered approach, you can call and request comprehensive in-home concierge services designed to accelerate and ease your recovery. There are many stages in the illness process, and MIT Holding is emerging as a single source provider of medical services for patients making the vital transition from stage three to stages four and five.

In 1965, research scientist Edward Suchman defined the stages of illness and the transition between them as:

1) The symptom experience stage
2) The sick role stage
3) The medical care stage
4) The dependent patient stage
5) The recovery or rehabilitation stage

Management at MIT Holding studied the five stages in today’s healthcare system and found that the two most crucial yet most ignored stages were four and five. Due to the fact that the fourth and fifth stages are often completed in the patient’s home, these final stages are the least studied. Other than the typical “see me in two weeks” checkup and physical therapy (if needed), there is limited professional medical involvement in the patient’s transition through recovery and rehabilitation.

The lack of services in the final stages – which MIT Holding deems the most stressful, because recovery is now on the patient’s shoulders – representing a dire need within the healthcare industry. Patients often feel a loss of control and sense of guilt as they become dependent on family members and friends for assistance. Some situations even introduce humiliation to the equation when a patient is bed ridden and in need of basic sanitary assistance.

When a loved one tells the patient they look great, the patient may shrug it off as empty words of kindness. When the professional tells them the same thing it tends to have a positive meaning and begins to incubate recovery on a mental level for the patient, as well as physical. Similarly, loved ones urging the patient to take their medication or rehabilitation is often dismissed by a patient. The same instructions coming from a healthcare professional are heeded as “doctor’s orders” and followed.

Following years of surveys and interviews with past and current patients, MIT Holding developed its concept of single source medical services to address these stages required for recovery and rehabilitation. By introducing MIT Holding’s medical professionals into the equation, the company aims to instill within each patient a renewed sense of dignity, responsibility, and focused level of control over their recovery. With the emotions and stress reduced, the result is quicker recovery and confidence building steps toward regained independence.

Through its research, MIT Holding also realized that by working directly with hospital discharge planners prior to release, the patient would experience a seamless transition from hospital to home. MIT Holding eliminates discharge hassles such as dealing with the bureaucratic hassles of the insurance companies, pharmacy, medical equipment suppliers and specialized transportation needs. MIT professionals have been trained and accredited to quickly and efficiently execute these arrangements on behalf of the patient.

The Centers for Disease Control (CDC) reports that the number of first-time pneumonia cases in the U.S. exceeds 35 million annually. The typical hospital stay is roughly five days followed by home recovery of four to six weeks depending on the severity of the case. Astoundingly, the recovery period alone can cost approximately $12,000 to $14,000, with no complications.

MIT Holding’s services drastically reduce these costs. Using a patient with pneumonia as an example, here is how the company’s solution works.

On the day of discharge from the hospital, the patient is met by an MIT Holding staff member, introduced to the company’s streamlined recovery process, and informed of the medical needs for their recovery period. The staff member will also explain to the patient all the options covered by their insurance and what will be the patient’s responsibility..

Pneumonia requires an antibiotic infusion often weekly for a four- to six-week period. Using MIT Holding’s services, the patient has the option of in-home care or access to one of MIT Holding’s local clinics to receive the treatment, which require a two- to four-hour administration session. Whether in the patient’s home or in the clinic, MIT Holding’s professional staff interacts with the patient to determine their individual needs throughout the treatment.

The staff also lobbies on the patient’s behalf for ancillary recovery needs. For example, patients recovering from pneumonia are advised to sleep in a reclined position. MIT Holding can verify if the insurance carrier will pay for a temporary rental of a hospital bed or medical recliner through recovery – and then make arrangements for its delivery and pick up. Should the patient live alone, MIT Holding can arrange for additional daily help as needed to maintain a sanitary recovery environment. In addition, the company’s compound pharmacy will deliver the antibiotics and other oral medication directly to the patient.

The extended time and personal care spent with the patient ensures that each patient receives every benefit to which they are entitled or choose to purchase for the most comfortable recovery possible. MIT Holding works with each patient to ease the burdens of recovery. Simply put MIT Holding deals in solutions – not problems!

MIT Holding has learned and proven that by extending superior care to the patient on multiple fronts, the company itself will benefit through multiple, growing revenue streams. Beta tests of this approach have shown an average increase in sales of up to 27% on a typical patient interaction – and the company is just getting started implementing its innovation into the U.S. healthcare system. Its potential has yet to be seen or achieved.

MIT Holding is pioneering the future of healthcare, positioned as the first-of-its-kind single source provider of medical services stemming from a convenient, all-inclusive concierge concept with no additional cost to the patient.

For more information, visit www.mitholdinginc.com

Let us hear your thoughts: MIT Holding, Inc. Message Board

Archives

Select A Month
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search

    Categories

    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (33)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • AlphaTrade.com APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • Barchart.com (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • BizRocket.com Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • Bollente Companies, Inc. BOLC (2)
  • BoonMarket.com (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises, Inc. CDII (38)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  • Chineseinvestors.com, Inc. CIIX (22)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • Connect-A-Jet.com CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (160)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (73)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • EFoodSafety.com Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz Inc. EPAZ (22)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Etelcharge.com Inc. ETLC (3)
  • Ethema Health Corporation GRST (7)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (81)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  • Fund.com, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • GainClients Inc. GCLT (9)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Payout Inc. GOHE (38)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • GotStocks.net (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • Greenstone Holdings Inc. GSHN (2)
  • GREM USA GRMU (2)
  • Grey Cloak Tech, Inc. GRCK (4)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital, Inc. IGC (17)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • InMed Pharmaceuticals, Inc. IMLFF (6)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (9)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kootenay Zinc Corp. KTNNF (2)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Loans4Less.com Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Transcription Billing Corp. MTBC (13)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • MGX Minerals, Inc. MGXMF (4)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (47)
  • Money4Gold Holdings Inc. MFGD (3)
  • MortgageBrokers.com Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (62)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • MyStaru.com Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • National Waste Management Holdings Inc. NWMH (24)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (19)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One Step Vending Corp. KOSK (2)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,352)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • ORHub, Inc. ORHB (6)
  • OTCPicks.com (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (78)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • PetroSun Inc. PSUD (41)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Player's Network, Inc. PNTV (3)
  • Players Network PNTV (4)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProBility Media Corp. PBYA (11)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (551)
  • QualityStocks Stock Newsletters (18,170)
  • QualityStocks Video Charts (286)
  • QualityStocks.net Market Basics (6)
  • QualityStocksNewsBreaks (11)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (73)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Skinny Nutritional Corp. SKNY (19)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • Smallcaps.us (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stealth Technologies, Inc. STTH (3)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,882)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune, Inc. TPIV (15)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.